NCT02198313View on ClinicalTrials.gov

A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

April 30, 1999

Conditions
Healthy
Interventions
DRUG

BIIX 1 XX - D1

DRUG

BIIX 1 XX - D2

DRUG

BIIX 1 XX - D3

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY